Clover Health Investments, Corp.
CLOV
$0.6283
-$0.0028-0.44%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 501.62M | 476.88M | 513.01M | 524.68M | 903.95M |
| Total Other Revenue | 4.59M | 4.80M | 5.76M | 4.91M | 4.96M |
| Total Revenue | 506.21M | 481.67M | 518.77M | 529.59M | 908.91M |
| Cost of Revenue | 447.99M | 418.96M | 436.95M | 472.49M | 893.65M |
| Gross Profit | 58.22M | 62.72M | 81.81M | 57.10M | 15.27M |
| SG&A Expenses | 109.93M | 102.31M | 104.87M | 129.42M | 124.35M |
| Depreciation & Amortization | 674.00K | 557.00K | 999.00K | 279.00K | -841.00K |
| Other Operating Expenses | -- | -- | -- | -- | 70.00K |
| Total Operating Expenses | 558.59M | 521.83M | 542.82M | 602.19M | 1.02B |
| Operating Income | -52.38M | -40.16M | -24.06M | -72.61M | -108.31M |
| Income Before Tax | -70.47M | -41.47M | -28.81M | -72.61M | -84.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -70.47M | -41.47M | -28.81M | -72.61M | -84.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -70.47M | -41.47M | -28.81M | -72.61M | -84.23M |
| EBIT | -52.38M | -40.16M | -24.06M | -72.61M | -108.31M |
| EBITDA | -52.05M | -39.60M | -23.06M | -72.33M | -108.05M |
| EPS Basic | -0.15 | -0.09 | -0.06 | -0.15 | -0.18 |
| Normalized Basic EPS | -0.07 | -0.05 | -0.03 | -0.09 | -0.14 |
| EPS Diluted | -0.15 | -0.09 | -0.06 | -0.15 | -0.18 |
| Normalized Diluted EPS | -0.07 | -0.05 | -0.03 | -0.09 | -0.14 |
| Average Basic Shares Outstanding | 481.61M | 480.77M | 479.16M | 478.81M | 477.90M |
| Average Diluted Shares Outstanding | 481.61M | 480.77M | 479.16M | 478.81M | 477.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
